Literature DB >> 8175855

Cure of the limp in children with congenital dislocation of the hip and ischaemic necrosis. Fifteen cases treated by trochanteric transfer and contralateral epiphysiodesis.

S Porat1, G C Robin, C B Howard.   

Abstract

Fifteen patients who limped and had early fatigue on walking caused by ischaemic necrosis after treatment for congenital dislocation of the hip had distal and lateral transfer of the greater trochanter. Nine of them in whom the predicted leg-length discrepancy was more than 3 cm also had epiphysiodesis of the contralateral leg. At skeletal maturity the limp was eliminated and walking distance was significantly improved in them all. In those who had epiphysiodesis the average leg-length discrepancy was 0.7 cm at maturity. Two of those not treated by epiphysiodesis used a heel raise of 1.5 cm. In seven cases the two operations were performed simultaneously without serious complications. This procedure is recommended at about the age of 12 years.

Entities:  

Mesh:

Year:  1994        PMID: 8175855

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  4 in total

1.  Trochanteric advancement in patients with Legg-Calvé-Perthes disease does not improve pain or limp.

Authors:  Sun Young Joo; Ki Seok Lee; Il Hyun Koh; Hui Wan Park; Hyun Woo Kim
Journal:  Clin Orthop Relat Res       Date:  2008-01-25       Impact factor: 4.176

2.  Does trochanteric transfer eliminate the Trendelenburg sign in adults?

Authors:  Flávio L Garcia; Celso H F Picado; Luís P Cardinali
Journal:  Clin Orthop Relat Res       Date:  2010-11-17       Impact factor: 4.176

3.  Hip impingement: beyond femoroacetabular.

Authors:  Nikolaos V Bardakos
Journal:  J Hip Preserv Surg       Date:  2015-07-16

4.  Overgrowth of the lower limb after treatment of developmental dysplasia of the hip: incidence and risk factors in 101 children with a mean follow-up of 15 years.

Authors:  Chan Yoon; Chang Ho Shin; Dong Ook Kim; Moon Seok Park; Won Joon Yoo; Chin Youb Chung; In Ho Choi; Tae-Joon Cho
Journal:  Acta Orthop       Date:  2019-11-12       Impact factor: 3.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.